These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 3314435)

  • 1. Fibrocystic breast disease.
    Scott EB
    Am Fam Physician; 1987 Oct; 36(4):119-26. PubMed ID: 3314435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of hormonal therapy of fibrocystic breast disease.
    Dogliotti L; Fioretti P; Melis GB; Mussa A; Angeli A
    Ann N Y Acad Sci; 1986; 464():350-63. PubMed ID: 3089096
    [No Abstract]   [Full Text] [Related]  

  • 3. [Update in the therapy of fibrocystic mastopathy].
    Zanoio L; Zacché G; Mainenti M; Silvestre V
    Minerva Ginecol; 1987 Dec; 39(12):833-8. PubMed ID: 3329703
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspects of fibrocystic disease of the breast. Treatment with danazol.
    Humphrey LJ; Estes NC
    Postgrad Med J; 1979; 55 Suppl 5():48-51. PubMed ID: 395520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine treatment of cyclical mastalgia/fibrocystic breast disease: update on the European trial.
    Dogliotti L; Mansel RE
    Br J Clin Pract Suppl; 1989 Nov; 68():26-32; discussion 49-53. PubMed ID: 2488563
    [No Abstract]   [Full Text] [Related]  

  • 6. [Danazol for treatment of fibrocystic mastopathy].
    von Fallois J; Etterli-Billenkamp U; Schindler EM; Schindler AE
    Zentralbl Gynakol; 1995; 117(9):457-65. PubMed ID: 7483879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine.
    Murta EF; de Freitas MM; Velludo MA
    Rev Paul Med; 1992; 110(6):251-6. PubMed ID: 1341021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up--the Hjørring project.
    Tobiassen T; Rasmussen T; Döberl A; Rannevik G
    Acta Obstet Gynecol Scand Suppl; 1984; 123():159-76. PubMed ID: 6594009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Danol (danazol) in the treatment of fibrocystic breast disease with mastodynia].
    Lorenz I
    Cas Lek Cesk; 1989 Feb; 128(7):209-11. PubMed ID: 2720755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal management of fibrocystic disease of the breast.
    Andrews WC
    J Reprod Med; 1990 Jan; 35(1 Suppl):87-90. PubMed ID: 2404118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of fibrocystic mastopathy with danazol (100mg/day) studied by thermo-echo-clinical examination].
    Dambrosio F; Dibisceglia G; Colombo A
    Ann Ostet Ginecol Med Perinat; 1989; Spec No():44-57. PubMed ID: 2672980
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrocystic changes.
    Fiorica JV
    Obstet Gynecol Clin North Am; 1994 Sep; 21(3):445-52. PubMed ID: 7816405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of danazol treatment of women with fibrocystic disease of breast].
    Baranowska B; Stopińska-Głuszak U
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):771-3. PubMed ID: 2701752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial of danazol for benign breast disease.
    Baker HW; Snedecor PA
    Am Surg; 1979 Nov; 45(11):727-9. PubMed ID: 391113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of fibrocystic breast disease with danazol. A multicenter study].
    Fioretti P; Paoletti AM; Petacchi FD; Prato R; Mauro GA; Melis GB
    Minerva Ginecol; 1988 Jul; 40(7):427-33. PubMed ID: 3062500
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrocystic disease of breast. Clinico-therapeutic considerations].
    Favia G; Lumachi F; D'Amico C; De Battisti S; Annunziata N; Berto M
    Minerva Chir; 1988 May; 43(9):759-62. PubMed ID: 3173746
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
    Vorherr H
    Am J Obstet Gynecol; 1986 Jan; 154(1):161-79. PubMed ID: 3511705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrocystic change and fibrocystic disease of the breast.
    Drukker BH; deMendonca WC
    Obstet Gynecol Clin North Am; 1987 Sep; 14(3):685-702. PubMed ID: 3323971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COMPARISONS BETWEEN THE NON-PROLIFERATIVE AND PROLIFERATIVE THERAPY IN FIBROCYSTIC MASTOSIS.
    Carauleanu A; Socolov R; Rugina V; Gabia O; Carauleanu DM; Lupascu IA; Socolov D
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):321-7. PubMed ID: 27483712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrocystic disorders of the breast].
    Tserotas K; Morán Villota C
    Ginecol Obstet Mex; 1998 Sep; 66():362-6. PubMed ID: 9789408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.